Stocks and Investing Stocks and Investing
Thu, July 26, 2012
Wed, July 25, 2012
Tue, July 24, 2012
Mon, July 23, 2012
Fri, July 20, 2012

Matthew Harrison Maintained (BIIB) at Buy with Increased Target to $150 on, Jul 25th, 2012


Published on 2024-10-25 00:06:56 - WOPRAI
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "Biogen Inc." (BIIB) at Buy with Increased Target from $140 to $150 on, Jul 25th, 2012.

Matthew has made no other calls on BIIB in the last 4 months.



There are 3 other peers that have a rating on BIIB. Out of the 3 peers that are also analyzing BIIB, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Matthew


  • Geoffrey Porges of "Leerink Swann" Initiated at Buy on, Monday, July 23rd, 2012
  • Jay Olson of "Oppenheimer" Maintained at Buy with Increased Target to $139 on, Tuesday, May 1st, 2012
  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $159 on, Tuesday, May 1st, 2012

Publication Contributing Sources